GlassScriptPhysician profile
Mary Williams
NPI 1164807798
$2,189.91
in general payments reported to CMS, 2019-2025
9 companies · $76.62 in 2025
The $76.62 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.45 · 2022: $89.72 · 2023: $1,533 · 2024: $474 · 2025: $76.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,038 · Food and Beverage: $976 · Travel and Lodging: $70.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,038.00 |
| Food and Beverage | $975.74 |
| Travel and Lodging | $70.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,790.81 | 2023-2024 | |
| Galderma Laboratories, L.P. | $157.76 | 2023-2024 | |
| Pacira Pharmaceuticals Incorporated | $89.72 | 2022 | |
| Cochlear Americas | $55.54 | 2025 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Takeda Pharmaceuticals U.S.A., INC. | $25.78 | 2024 | Ninlaro |
| Tersera Therapeutics LLC | $21.08 | 2025 | Zoladex |
| Astrazeneca Pharmaceuticals LP | $19.26 | 2024 | Wainua |
| Baudax Bio INC. | $16.45 | 2021 | |
| Abiomed | $13.51 | 2024 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.